Roivant Sciences Ltd. (ROIV) Revenue by Segment
Roivant Sciences revenue by segment at a glance
In Q1 fiscal 2024 (the quarter ended June 30, 2024), Roivant Sciences's largest product or service was License, Milestone and Other Revenue, with $36.77 million or 67% of revenue, up 640.5% from a year earlier. Next: Product (33%).
The fastest-growing product or service from a year earlier was License, Milestone and Other Revenue (+640.5%).
From company filings, in USD; latest quarter ended June 30, 2024; quarterly data from Q1 fiscal 2022.
Roivant Sciences Ltd.
ROIV
Healthcare
Revenue breakdown
Fiscal quarters, from company filings
Roivant Sciences revenue by product or service, last 4 quarters
| Product or service | Q1 FY24 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Share |
|---|---|---|---|---|---|
| License, Milestone and Other Revenue | $36.8M | $16.5M | $18.7M | $5.0M | 67% |
| Product | $18.4M | $20.7M | $18.4M | $16.7M | 33% |
In USD, fiscal quarters as reported; share = part of Q1 FY24 revenue.
Questions and answers
Which product or service makes the most money for Roivant Sciences?
License, Milestone and Other Revenue: $36.77 million, or 67% of revenue, in Q1 fiscal 2024.
What are Roivant Sciences's main products and services?
By revenue in Q1 fiscal 2024: License, Milestone and Other Revenue (67%) and Product (33%).
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
